A carregar...
Ra223 in Bone Metastases with Osteolytic Activity
Radium 223 dichloride (Ra223) is the only targeted alpha therapy able to extend survival in patients with bone metastases from prostate cancer. Mechanism of action and data currently available focused mainly on osteoblastic metastases from prostate cancer. In our institution, a patient with breast c...
Na minha lista:
| Publicado no: | World J Nucl Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5905256/ https://ncbi.nlm.nih.gov/pubmed/29719487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/wjnm.WJNM_22_17 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|